Drug–carrier interaction analysis in the cell penetrating peptide-modified liposomes for doxorubicin loading

References

• Allen TM, Sapra P, Moase E. Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell Mol Biol Lett, 2002;7(3):889–94
   PubMed Web of Science ®Google Scholar
• Ashok B, Arleth L, Hjelm RP, Rubinstein I, Onyuksel H. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: Effects of PEG chain length and PC incorporation. J Pharm Sci, 2004;93(10):2476–87
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Doxil(R) – The first FDA-approved nano-drug: Lessons learned. J Control Release, 2012;160(2):117–34
   PubMed Web of Science ®Google Scholar
• Biswas S, Deshpande PP, Perche F, Dodwadkar NS, Sane SD, Torchilin VP. Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer. Cancer Lett, 2013;335(1):191–200
   PubMed Web of Science ®Google Scholar
• Darden T, York D, Pedersen L. Particle Mesh Ewald – An N.Log(N) method for ewald sums in large systems. J Chem Phys, 1993;98(12):10089–92
   Web of Science ®Google Scholar
• Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T, et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem, 2003;24(16):1999–2012
   PubMed Web of Science ®Google Scholar
• El-Sayed A, Futaki S, Harashima H. Delivery of macromolecules using arginine-rich cell-penetrating peptides: Ways to overcome endosomal entrapment. AAPS J, 2009;11(1):13–22
   PubMed Web of Science ®Google Scholar
• Elhissi AM, O'Neill MA, Roberts SA, Taylor KM. A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid-liposome interactions for liposomes prepared by thin film and proliposome methods. Int J Pharm, 2006;320(1–2):124–30
   PubMed Web of Science ®Google Scholar
• Fornari FA, Randolph JK, Yalowich JC, Ritke MK, Gewirtz DA. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol, 1994;45(4):649–56
   PubMed Web of Science ®Google Scholar
• Gallivan JP, Dougherty DA. Cation-pi interactions in structural biology. Proc Natl Acad Sci USA, 1999;96(17):9459–64
   PubMed Web of Science ®Google Scholar
• Guterstam P, Andaloussi SE, Langel U. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery. Methods Mol Biol, 2011;683:219–30
   PubMedGoogle Scholar
• Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput, 2008;4(3):435–47
   PubMed Web of Science ®Google Scholar
• Hira SK, Mishra AK, Ray B, Manna PP. Targeted delivery of doxorubicin-loaded poly (epsilon-caprolactone)-b-poly (N-vinylpyrrolidone) micelles enhances antitumor effect in lymphoma. PLoS One, 2014;9(4):e94309
   PubMed Web of Science ®Google Scholar
• Horowitz AT, Barenholz Y, Gabizon AA. In vitro cytotoxicity of liposome-encapsulated doxorubicin: Dependence on liposome composition and drug release. Biochim Biophys Acta, 1992;1109(2):203–9
   PubMed Web of Science ®Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph Model, 1996;14(1):33–8
   Web of Science ®Google Scholar
• Iranshahi M, Barthomeuf C, Bayet-Robert M, Chollet P, Davoodi D, Piacente S, Rezaee R, Sahebkar A. Drimane-type sesquiterpene coumarins from ferula gummosa fruits enhance doxorubicin uptake in doxorubicin-resistant human breast cancer cell line. J Tradit Complement Med, 2014;4(2):118–25
   Google Scholar
• Jo J, Hong S, Choi WY, Lee DR. Cell-penetrating peptide (CPP)-conjugated proteins is an efficient tool for manipulation of human mesenchymal stromal cells. Sci Rep, 2014;4:4378
   PubMedGoogle Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys, 1983;79(2):926–35
   Web of Science ®Google Scholar
• Lei H, Wang X, Wu C. Early stage intercalation of doxorubicin to DNA fragments observed in molecular dynamics binding simulations. J Mol Graph Model, 2012;38:279–89
   PubMed Web of Science ®Google Scholar
• Momparler RL, Karon M, Siegel SE, Avila F. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res, 1976;36(8):2891–5
   PubMed Web of Science ®Google Scholar
• Mykytczuk NC, Trevors JT, Leduc LG, Ferroni GD. Fluorescence polarization in studies of bacterial cytoplasmic membrane fluidity under environmental stress. Prog Biophys Mol Biol, 2007;95(1–3):60–82
   PubMed Web of Science ®Google Scholar
• Nakase I, Konishi Y, Ueda M, Saji H, Futaki S. Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo. J Control Release, 2012;159(2):181–8
   PubMed Web of Science ®Google Scholar
• Nose S. A unified formulation of the constant temperature molecular-dynamics methods. J Chem Phys, 1984;81(1):511–19
   Web of Science ®Google Scholar
• Plosker GL. Pegylated liposomal Doxorubicin: A review of its use in the treatment of relapsed or refractory multiple myeloma. Drugs, 2008;68(17):2535–51
   PubMed Web of Science ®Google Scholar
• Raagel H, Saalik P, Hansen M, Langel U, Pooga M. CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway. J Control Release, 2009;139(2):108–17
   PubMed Web of Science ®Google Scholar
• Shaikh IM, Tan KB, Chaudhury A, Liu Y, Tan BJ, Tan BM, Chiu GN. Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft. J Control Release, 2013;172(3):852–61
   PubMed Web of Science ®Google Scholar
• Staropoli N, Ciliberto D, Botta C, Fiorillo L, Grimaldi A, Lama S, Caraglia M, Salvino A, Tassone P, Tagliaferri P. Pegylated liposomal doxorubicin in the management of ovarian cancer: A systematic review and metaanalysis of randomised trials. Cancer Biol Ther, 2014;15(6):707–20
   PubMed Web of Science ®Google Scholar
• Tagami T, Ernsting MJ, Li SD. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. J Control Release, 2011;154(3):290–7
   PubMed Web of Science ®Google Scholar
• Wells RA, Kellie JL, Wetmore SD. Significant strength of charged DNA-protein pi-pi interactions: A preliminary study of cytosine. J Phys Chem B, 2013;117(36):10462–74
   PubMed Web of Science ®Google Scholar
• Werner M, Atil B, Sieczkowski E, Chiba P, Hohenegger M. Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells. Naunyn Schmiedebergs Arch Pharmacol, 2013;386(7):605–17
   PubMed Web of Science ®Google Scholar
• Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, Men Y, Zhang Y, Li RJ, Yang TY, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release, 2010;141(2):183–92
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med, 2012;18(11):1639–42
   PubMed Web of Science ®Google Scholar
• Zhang X, Kirsch LE. The physical stability of thermally-stressed phospholipid-based emulsions containing methyl, propyl and heptyl parabens as model drugs. Int J Pharm, 2003;265(1–2):133–40
   PubMed Web of Science ®Google Scholar
• Ziegler A, Nervi P, Durrenberger M, Seelig J. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: Optical, biophysical, and metabolic evidence. Biochemistry, 2005;44(1):138–48
   PubMed Web of Science ®Google Scholar